Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Globenewswire

Published November 17, 2026

BetterLife Pharma Announces New Preclinical Research - GlobeNewswire

Read the full story at Globenewswire

Single-nucleus RNA sequencing identifies molecular responses overlapping with LSD , providing additional scientific support for BetterLife's.

Surfaced by 4 Google Alerts

  • LSD
  • Psychedelic press release
  • Psychedelic biotech
  • Psychedelics